Gly-pro-glu Uses, Dosage, Side Effects and more
Neuren Pharmaceuticals was developing Gly-pro-glu (glycine-proline glutamate), a naturally occurring small-molecule neuroprotectant derived from IGF-1 which inhibits caspase III dependent apoptosis, for the potential treatment of neurodegenerative diseases by IV infusion. In December 2008, the company discontinued further development of the drug after it failed to show an observable effect.
| Attribute | Details |
|---|---|
| Trade Name | Gly-pro-glu |
| Generic | Glypromate |
| Glypromate Other Names | Gly-pro-glu |
| Type | |
| Formula | C12H19N3O6 |
| Weight | Average: 301.299 Monoisotopic: 301.127385344 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in neurologic disorders.
